vitamin D deficiency/insufficiency in healthy adult Indonesian women
Conditions
Interventions
Intervention group: Vitamin D3 3200 IU combined with zinc bisglycinate and quercetin phytosome (Imune), administered orally once daily for 8 weeks
Control group: Vitamin D3 3200 IU monotherapy, admini
Sponsors
Faculty of Medicine and Health Sciences, Universitas Katolik Indonesia Atma Jaya
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Healthy adult women aged 18-65 years No history of chronic disease( e.g cardiovascular, liver, kidney, diabetes, autoimnune disorders) Not taking vitamin D supplementation within at least 2 weeks prior to study Willing to participate and provide informed consent
Exclusion criteria
Exclusion criteria: Pregnancy or breastfeeding Use of medications affecting vitamin D metabolism (e.g., corticosteroids, antiepileptics, statins, metformin) Presence of chronic illnesses Current participation in other clinical studies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in serum 25-hydroxyvitamin D [25(OH)D] levels from baseline to 8 weeks after supplementation | — |
Secondary
| Measure | Time frame |
|---|---|
| - Changes in hematological parameters (hemoglobin, hematocrit, erythrocyte count, leukocyte count) - Changes in body composition (body fat percentage, visceral fat, muscle mass, total body water) - Correlation between changes in vitamin D levels and immunometabolic parameters | — |
Countries
Asia(except Japan)
Contacts
Public ContactLinawati Hananta
Faculty of Medicine and Health Sciences, Universitas Katolik Indonesia Atma Jaya Pharmacology
Outcome results
None listed